Xie, H., Zhu, Y., An, H., Wang, H., Zhu, Y., Fu, H., . . . Ye, D. (2016). Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma. Oncotarget.
Chicago-tyylinen lähdeviittausXie, Huyang, et al. "Increased B4GALT1 Expression Associates With Adverse Outcome in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma." Oncotarget 2016.
MLA-viiteXie, Huyang, et al. "Increased B4GALT1 Expression Associates With Adverse Outcome in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma." Oncotarget 2016.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.